Tomer Kariv - Net Worth and Insider Trading
Tomer Kariv Net Worth
The estimated net worth of Tomer Kariv is at least $245 Million dollars as of 2024-06-14. Tomer Kariv is the Director, 10% Owner of Keros Therapeutics Inc and owns about 4,794,507 shares of Keros Therapeutics Inc (KROS) stock worth over $234 Million. Tomer Kariv is the Director, 10% Owner of 89bio Inc and owns about 1,134,671 shares of 89bio Inc (ETNB) stock worth over $10 Million. Tomer Kariv is also the Director of Eloxx Pharmaceuticals Inc and owns about 122,506 shares of Eloxx Pharmaceuticals Inc (ELOX) stock worth over $98,005. Besides these, Tomer Kariv also holds VBI Vaccines Inc (VBIV) , Arno Therapeutics Inc (ARNI) , Logic Devices Inc (LOGC) . Details can be seen in Tomer Kariv's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tomer Kariv has not made any transactions after 2020-11-17 and currently still holds the listed stock(s).
Transaction Summary of Tomer Kariv
Tomer Kariv Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tomer Kariv owns 6 companies in total, including Eloxx Pharmaceuticals Inc (ELOX) , Keros Therapeutics Inc (KROS) , and LogicBio Therapeutics Inc (LOGC) among others .
Click here to see the complete history of Tomer Kariv’s form 4 insider trades.
Insider Ownership Summary of Tomer Kariv
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELOX | Eloxx Pharmaceuticals Inc | 2021-05-13 | director |
| KROS | Keros Therapeutics Inc | 2020-11-17 | director & 10 percent owner |
| LOGC | LogicBio Therapeutics Inc | 2018-10-18 | director |
 | | 2019-11-11 | director & 10 percent owner |
| | 2018-12-17 | director |
| | 2016-08-15 | director |
Tomer Kariv Latest Holdings Summary
Tomer Kariv currently owns a total of 6 stocks. Among these stocks, Tomer Kariv owns 4,794,507 shares of Keros Therapeutics Inc (KROS) as of November 17, 2020, with a value of $234 Million and a weighting of 95.69%. Tomer Kariv owns 1,134,671 shares of 89bio Inc (ETNB) as of November 11, 2019, with a value of $10 Million and a weighting of 4.24%. Tomer Kariv also owns 122,506 shares of Eloxx Pharmaceuticals Inc (ELOX) as of June 24, 2019, with a value of $98,005 and a weighting of 0.04%. The other 3 stocks VBI Vaccines Inc (VBIV) , Arno Therapeutics Inc (ARNI) , Logic Devices Inc (LOGC) have a combined weighting of 0.03% among all his current holdings.
Latest Holdings of Tomer Kariv
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KROS | Keros Therapeutics Inc | 2020-11-17 | 4,794,507 | 48.89 | 234,403,447 |
| ETNB | 89bio Inc | 2019-11-11 | 1,134,671 | 9.16 | 10,393,586 |
| ELOX | Eloxx Pharmaceuticals Inc | 2019-06-24 | 122,506 | 0.80 | 98,005 |
| VBIV | VBI Vaccines Inc | 2018-12-17 | 124,122 | 0.60 | 74,479 |
| ARNI | Arno Therapeutics Inc | 2016-01-12 | 2,756,183 | 0.00 | 827 |
| LOGC | Logic Devices Inc | 2018-10-23 | 5,048,541 | 0.00 | 0 |
Holding Weightings of Tomer Kariv
Tomer Kariv Form 4 Trading Tracker
According to the SEC Form 4 filings, Tomer Kariv has made a total of 2 transactions in Keros Therapeutics Inc (KROS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Keros Therapeutics Inc is the acquisition of 60,000 shares on November 17, 2020, which cost Tomer Kariv around $3 Million.
According to the SEC Form 4 filings, Tomer Kariv has made a total of 1 transactions in 89bio Inc (ETNB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in 89bio Inc is the acquisition of 250,000 shares on November 11, 2019, which cost Tomer Kariv around $4 Million.
According to the SEC Form 4 filings, Tomer Kariv has made a total of 1 transactions in Eloxx Pharmaceuticals Inc (ELOX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Eloxx Pharmaceuticals Inc is the acquisition of 5,000 shares on June 24, 2019, which cost Tomer Kariv around $2 Million.
More details on Tomer Kariv's insider transactions can be found in the Insider Trading History of Tomer Kariv table.Insider Trading History of Tomer Kariv
- 1
Tomer Kariv Trading Performance
GuruFocus tracks the stock performance after each of Tomer Kariv's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tomer Kariv is 19.17%. GuruFocus also compares Tomer Kariv's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tomer Kariv within 3 months outperforms 6 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Tomer Kariv's insider trading performs compared to the benchmark.
Performance of Tomer Kariv
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 25.06 | | | | | |
| Relative Return to S&P 500(%) | 24.02 | | | | | |
Tomer Kariv Ownership Network
Tomer Kariv Owned Company Details
What does Eloxx Pharmaceuticals Inc do?
Who are the key executives at Eloxx Pharmaceuticals Inc?
Tomer Kariv is the director of Eloxx Pharmaceuticals Inc. Other key executives at Eloxx Pharmaceuticals Inc include HEAD OF R&D Vijay Modur , director & PRESIDENT AND CEO Sumit Aggarwal , and Chief Financial Officer Daniel E. Geffken .
Eloxx Pharmaceuticals Inc (ELOX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eloxx Pharmaceuticals Inc (ELOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eloxx Pharmaceuticals Inc (ELOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eloxx Pharmaceuticals Inc (ELOX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eloxx Pharmaceuticals Inc Insider Transactions
Tomer Kariv Mailing Address
Above is the net worth, insider trading, and ownership report for Tomer Kariv. You might contact Tomer Kariv via mailing address: C/o Arno Therapeutics, Inc., 200 Route 31 North, Suite 104, Flemington Nj 08822.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
